Mitochondrial Cytoprotective Compounds for ROS Damage Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments are inadequate for addressing diseases associated with decreased mitochondrial function, leading to diminished ATP production and oxidative stress, which are linked to neurodegenerative diseases and other conditions.
Innovation Solution
Development of compounds that provide cytoprotection, quench ROS, maintain mitochondrial membrane potential, and increase frataxin levels, specifically targeting mitochondrial disorders and related diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for mitochondrial diseases, then some symptomatic relief may be achieved, but the underlying mitochondrial dysfunction and oxidative stress remain unaddressed
Solution Approach 1:
The patent applies this principle by using antioxidants and mitochondrial protective agents that convert the harmful oxidative stress environment into a beneficial therapeutic effect. The compounds specifically target and neutralize ROS while protecting mitochondrial structures, thereby converting the harmful oxidative condition into a therapeutic opportunity to restore mitochondrial function and reduce disease progression
Solution Approach 2:
The patent employs mitochondrial protective agents and antioxidants as intermediary substances that mediate between the harmful ROS environment and the vulnerable mitochondrial structures. These intermediaries scavenge free radicals, chelate metal ions, and protect mitochondrial membranes and DNA, thereby preventing direct damage while maintaining cellular function
2Use of energy by moving object
If mitochondrial function is enhanced to increase ATP production, then energy metabolism improves, but oxidative stress and ROS generation may increase
Solution Approach 1:
The patent applies parameter changes by modifying the redox balance parameters and mitochondrial membrane potential through targeted administration of antioxidants and metabolic modulators. The treatment shifts the oxidative parameters toward a more reduced state, protecting against ROS while maintaining or enhancing ATP production through improved mitochondrial efficiency rather than increased electron leak
Solution Approach 2:
The patent applies local quality by providing differential protection to different mitochondrial components and cellular compartments. Antioxidants are targeted specifically to mitochondrial matrices and membranes where ROS generation occurs, while separate metabolic agents enhance ATP synthesis in the electron transport chain. This localized approach allows simultaneous enhancement of energy production and protection against oxidative damage in specific mitochondrial regions
Data Source
AI summary
The invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1 has any of the values described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as cytoprotective agents.